An immunoturbidimetric assay (or particle-enhanced turbidimetric immunoassay (PETIA)) for measuring Calprotectin is the fastest solution in the market with the shortest time to first result regardless of using sample batches or random access.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Calprotectin Dossier
Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as can be seen in many chronic diseases. IBD includes several different diseases; the two most important ones are Ulcerative Colitis (UC), with inflammation localized mostly in the colon, and Crohn’s Disease (CD)
The published evidence for the clinical validity of the calprotectin ELISA and Quantum Blue® rapid test is ever increasing and described for the diagnosis of IBD vs IBS, as well as for the monitoring of IBD patients during the course of their disease. Please find the printversion of the study summaries here. 1) DIAGNOSIS OF
Social Links